Our group has been focusing on how we can utilize human induced pluripotent stem cells (iPSCs) to model neural and muscle diseases in a hope to develop new therapeutic strategies. My lab is one of the first teams who utilized human iPSCs for disease modelling and drug discovery/validation, and recently we developed new human iPSC-based cell therapies for degenerative diseases and aging.
